10-Q: Eastman Chemical Q3 Earnings Plunge Amid Weak Demand

Eastman Chemical Company reports significant declines in sales and profitability for the third quarter and first nine months of 2025, driven by broad market weakness and increased tax provisions.

Summary

• Sales for the third quarter of 2025 decreased by 11% to $2,202 million compared to $2,464 million in Q3 2024.
• Net earnings attributable to Eastman for Q3 2025 fell by 74% to $47 million, down from $180 million in Q3 2024.
• Diluted earnings per share (EPS) for Q3 2025 was $0.40, a substantial decrease from $1.53 in Q3 2024.
• For the first nine months of 2025, sales decreased by 5% to $6,779 million from $7,137 million in the same period of 2024.
• Net earnings attributable to Eastman for the first nine months of 2025 were $369 million, a 36% drop from $575 million in the prior year period.
• Diluted EPS for the first nine months of 2025 was $3.18, down from $4.86 in the first nine months of 2024.
• Operating cash flow for the first nine months of 2025 was $468 million, a decrease from $747 million in the same period of 2024.
• The provision for income taxes in Q3 and 9M 2025 included a $22 million increase due to the 'One Big Beautiful Bill Act' and a $35 million increase for uncertain tax positions in 9M 2025.
• The U.S. Department of Energy (DOE) terminated an award related to the Polyethylene Terephthalate Recycling Decarbonization Project on May 29, 2025, with $14 million in reimbursements received out of $19 million requested.
• Net debt increased to $4,586 million at September 30, 2025, from $4,180 million at December 31, 2024.

Sentiment

Score: 3

Explanation: The overall sentiment is negative due to significant declines in sales, gross profit, EBIT, and net earnings across most segments. Increased net debt, a terminated government grant for a strategic project, and ongoing market weaknesses contribute to a challenging outlook, despite some cost reduction efforts.

Positives

• Selling, general and administrative (SG&A) expenses decreased by 13% in Q3 2025 and 10% in 9M 2025, primarily due to cost reduction initiatives and lower variable compensation costs.
• Research and development (R&D) expenses decreased by 3% in Q3 2025 due to targeted cost reduction initiatives.
• Additives & Functional Products segment showed a 2% increase in sales and a 17% increase in Adjusted EBIT for the first nine months of 2025, driven by higher selling prices from cost-pass-through contracts.

Negatives

• Sales revenue decreased across all segments in Q3 2025 and in all segments except AFP for 9M 2025, primarily due to lower sales volume and unfavorable product mix.
• Gross profit decreased by 28% in Q3 2025 and 13% in 9M 2025.
• Earnings before interest and taxes (EBIT) decreased by 43% in Q3 2025 and 23% in 9M 2025.
• Net interest expense increased by 10% in Q3 2025 and 5% in 9M 2025 due to higher borrowings and less capitalized interest.
• Advanced Materials segment sales decreased by 7% in Q3 2025 and 5% in 9M 2025, with Adjusted EBIT falling by 57% and 19% respectively, due to weak demand in building and construction and consumer durables.
• Chemical Intermediates segment sales decreased by 16% in Q3 2025 and 8% in 9M 2025, with Adjusted EBIT plummeting by 98% and 112% (resulting in a loss) respectively, due to weak market demand and lower selling prices.
• Fibers segment sales decreased by 24% in Q3 2025 and 18% in 9M 2025, with Adjusted EBIT decreasing by 40% and 33% respectively, attributed to destocking, industry capacity adjustments, and tariff risk impacts in China.
• Cash provided by operating activities decreased by $279 million in the first nine months of 2025 compared to 2024, primarily due to lower accounts payable, lower net earnings, and higher variable compensation payout.
• Cash and cash equivalents decreased to $489 million at September 30, 2025, from $837 million at the beginning of the period.

Risks

• Continued weakness in global and regional economic conditions, including heightened inflation, capital market volatility, interest rate and currency fluctuations, and economic slowdown or recession.
• Disruption or interruption of operations and of raw material or energy supply, including as a result of cyber-attacks or other breaches of information security systems.
• Impacts from U.S. tariffs, reciprocal tariffs, and global trade disruption, which negatively affected demand in the Fibers segment.
• Potential for asset impairments, particularly for the performance films reporting unit within the Advanced Materials segment, which has $811 million in goodwill and has experienced declines due to macro environment, low automotive builds, and global trade impacts.
• Uncertainties related to environmental matters, which could have a material adverse effect on financial statements, results of operations, or cash flows.
• Exposure to market risks from changes in foreign currency exchange rates, raw material and energy prices, and interest rates.
• The termination of the U.S. Department of Energy award for the Polyethylene Terephthalate Recycling Decarbonization Project could impact the project's scope, timeline, and carrying values of associated assets.

Future Outlook

Management believes its innovation-driven growth model, disciplined portfolio management, and balanced capital deployment will lead to consistent, sustainable earnings growth and strong cash flow from operations. Capital expenditures for 2025 are expected to be approximately $550 million, primarily for targeted growth initiatives, including the Advanced Materials segment's methanolysis plastic-to-plastic molecular recycling manufacturing facilities, and site modernization projects. The company expects to elect the practical expedient for ASU 2025-05 upon adoption and does not anticipate a material impact on financial statements.

Management Comments

• Management evaluates Company and operating segment performance, and makes resource allocation and performance evaluation decisions, excluding the effect of transactions, costs, and losses or gains that do not directly result from Eastman's normal, or 'core', business and operations, or are otherwise of an unusual or non-recurring nature.
• Management believes maintaining a financial profile that supports an investment grade credit rating is important to its long-term strategy and financial flexibility.
• Management believes the critical accounting estimates described in Part II, Item 7 of the Company's 2024 Annual Report on Form 10-K are the most important to the fair presentation of the Company's financial condition and results.
• Management does not believe it is more likely than not that goodwill was impaired for each of its reporting units as of September 30, 2025, but acknowledges that additional declines in market conditions or forecasted revenue and earnings for the performance films reporting unit could result in an impairment.

Industry Context

The company's performance was significantly impacted by continued weakness across key end markets, including building and construction, consumer durables, and industrial sectors. Customer caution due to uncertainty surrounding global trade policy and tariff risks, particularly affecting textiles sales into China, further exacerbated demand issues. Higher raw material and energy costs also contributed to reduced profitability, reflecting broader inflationary pressures and supply chain dynamics within the chemical industry.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• Eastman and its operations are parties to, or targets of, various lawsuits, claims, investigations, and proceedings, including product liability, personal injury, asbestos, patent and intellectual property, commercial, contract, environmental, antitrust, health and safety, and employment matters.
• Management does not believe that the ultimate resolution of any such pending matters will have a material adverse effect on its overall financial position, results of operations, or cash flows, based on currently available facts.
• The company's threshold for disclosing environmental legal proceedings involving a governmental authority is potential monetary sanctions of $1 million or more.
• Solutia, a wholly-owned subsidiary, has been named as a defendant in several Legacy Tort Claims, which are submitted to Monsanto (now Bayer AG) for defense and indemnification under the Monsanto Settlement Agreement. Eastman guarantees Solutia's obligations and is an indemnified party under this agreement.

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: Significant decrease in net earnings and EPS, along with increased net debt, could negatively impact shareholder value and future dividend growth potential, despite ongoing share repurchases.
• Employees: Cost reduction initiatives and restructuring activities, including severance charges of $14 million in Q3 2025 and $25 million in 9M 2025, indicate potential workforce reductions.
• Customers: Weak demand across key end markets and customer caution due to global trade policy uncertainty suggest challenges in customer relationships and sales volumes.
• Suppliers: The voluntary supplier finance program aims to optimize payment terms, potentially benefiting suppliers by offering early payment options through financial institutions.
• Creditors: Increased total borrowings and net debt, along with higher net interest expense, could raise concerns about the company's leverage, although it remains in compliance with debt covenants and aims to maintain an investment-grade credit rating.

Next Steps

• Continue evaluating the impact of the DOE award termination on the Polyethylene Terephthalate Recycling Decarbonization Project's scope, timeline, and asset carrying values, and pursue a settlement proposal if reinstatement is not obtained.
• Remeasure the U.S. other postretirement benefit plan in the fourth quarter of 2025 following an amendment in October 2025.
• Continue strategic investment in innovation, including the Advanced Materials segment's methanolysis plastic-to-plastic molecular recycling manufacturing facilities and site modernization projects, with expected capital expenditures of approximately $550 million for 2025.
• Management will continue to evaluate its estimates, including those related to impairment of long-lived assets, environmental costs, pension and other postretirement benefits, litigation and contingent liabilities, and income taxes.

Key Dates

Recommendation

The filing reveals a substantial deterioration in Eastman Chemical Company's financial performance, with significant year-over-year declines in sales, gross profit, EBIT, and net earnings for both the third quarter and the first nine months of 2025. Key segments like Advanced Materials, Chemical Intermediates, and Fibers are experiencing severe headwinds from weak market demand, lower selling prices, and global trade uncertainties. The Chemical Intermediates segment even reported a negative Adjusted EBIT for the nine-month period. Furthermore, operating cash flow has decreased, net debt has risen, and a critical government grant for a molecular recycling project was terminated, adding to operational and strategic uncertainty. While some cost reduction efforts are noted, they are insufficient to offset the broad-based challenges. The potential for goodwill impairment in the performance films unit also presents a downside risk. Given the widespread underperformance and negative outlook, a strong sell recommendation is warranted for investors.

Keywords

Specialty Chemicals, Advanced Materials, Additives, Functional Products, Chemical Intermediates, Fibers, SEC Filing, 10-Q, Quarterly Report, Earnings, Sales, EBIT, EPS, Cash Flow, Debt, Recycling, Sustainability, Corporate Governance